JP Patent

JP7625614B2 — 液体サンプルの成分を除去するために使用されるマトリックスならびに関連のサンプルカップまたは混合カップ

Assigned to Idexx Laboratories Inc · Expires 2025-02-03 · 1y expired

What this patent protects

Patent listed against Abilify.

Drugs covered by this patent

Abilify (aripiprazole) · Generic (originally Otsuka/BMS)

Patent Metadata

Patent number: JP7625614B2
Jurisdiction: JP
Classification: —
Expires: 2025-02-03
Drug substance claim: No
Drug product claim: No
Assignee: Idexx Laboratories Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.